Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms

NCT06117891 2026-04-15

REFINE-IO

Recruiting

300 enrolled

Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT06077500 2026-04-14

DAREONᵀᴹ-8

Phase 1 Active not recruiting

46 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07155174 2026-04-14

SEZanne

Phase 2 Recruiting

180 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07291076 2026-04-14

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Phase 1/2 Recruiting

129 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT03148418 2026-04-13

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Phase 3 Active not recruiting

382 enrolled

Tumor-Agnostic

Neoplasms

NCT04802759 2026-04-13

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Phase 1/2 Recruiting

316 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05595460 2026-04-13

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Phase 1 Active not recruiting

21 enrolled

Thoracic

SCLC,Extensive Stage

NCT05862285 2026-04-13

UmbrellaMAX

Phase 3 Recruiting

100 enrolled

Tumor-Agnostic

Neoplasms

NCT05968326 2026-04-13

IMCODE003

Phase 2 Recruiting

260 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT07227597 2026-04-13

MK-6070-003

Phase 1/2 Recruiting

170 enrolled

Thoracic

Small Cell Lung Cancer Extensive Stage

NCT04540211 2026-04-09

SKYSCRAPER-08

Phase 3 Completed

461 enrolled 24 charts

Gastrointestinal

Esophageal Neoplasms

NCT07190833 2026-04-09

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Phase 1 Recruiting

27 enrolled

Other solid neoplasm

Treatment-Refractory Solid Tumors

NCT07235293 2026-04-09

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Phase 2 Recruiting

90 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07407933 2026-04-09

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

118 enrolled

Thoracic

Lung Diseases, Thoracic Neoplasms, Small Cell Lung Carcinoma

NCT07195695 2026-04-08

Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Phase 3 Recruiting

400 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07226999 2026-04-08

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Phase 2/3 Recruiting

550 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06444815 2026-04-07

STEALTH-001

Phase 1 Recruiting

60 enrolled

DermatologicGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Kidney Neoplasms, Melanoma, Mesothelioma

NCT07170592 2026-04-07